Interaction between a commercially available St. John’s wort product (Movina) and atorvastatin in patients with hypercholesterolemia

Author： Andrén L.   Andreasson Å   Eggertsen R.  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.63, Iss.10, 2007-10, pp. : 913-916

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

St John’s Wort: A Potential Therapy for Elderly Depressed Patients?

By Vorbach E.U.   Arnoldt K.H.   Wolpert E.  

Drugs & Aging, Vol. 16, Iss. 3, 2000-03 ,pp. : 189-197

Adis International

Access to resources Recommend Favorite

Drug Interactions with St John’s Wort: Mechanisms and Clinical Implications

By Marcus Mannel  

Drug Safety, Vol. 27, Iss. 11, 2004-01 ,pp. : 773-797

Adis International

Access to resources Recommend Favorite

Mechanism of Action of St John’s Wort in Depression: What is Known?

By Butterweck V.  

CNS Drugs, Vol. 17, Iss. 8, 2003-01 ,pp. : 539-562

Adis International

Access to resources Recommend Favorite

Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John’s wort

By Gödtel-Armbrust Ute   Metzger Annegret   Kroll Ulrike   Kelber Olaf   Wojnowski Leszek  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 6, 2007-08 ,pp. : 377-382

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Assessment of Effects of Botanical Supplementation on Cytochrome P450 Phenotypes in the Elderly: St John’s Wort, Garlic Oil, Panax ginseng and Ginkgo biloba

By Gurley Bill J.  

Drugs & Aging, Vol. 22, Iss. 6, 2005-01 ,pp. : 525-539

Adis International

Access to resources Recommend Favorite